Breath Therapeutics
Series AMunich, GermanyMar 2017
Breath Therapeutics raised €44M in a Series A round in Mar 2017. The company is based in Munich, Germany. Investors in the round: Gilde Healthcare, GIMV, Sofinnova Partners. Data as of Nov 2026.
Amount raised
€44M
€43,500,000
Native amount
43,500,000 EUR
Stage
Series A
series a
Investors
3
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €44M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Mar 2017
Round type
series a
Amount (EUR)
€44M
Other rounds
same companyThis is the company's only recorded round.